Why AST SpaceMobile Stock Surged Higher Friday
AST SpaceMobile successfully sends its first five satellites into orbit.
Mindfully Curated
AST SpaceMobile successfully sends its first five satellites into orbit.
Nuclear energy and uranium got a boost, but will it last given the long lead times to grow nuclear energy production?
Arm saw more analyst love, this time from Raymond James.
Dogecoin is once again on the move higher today, surging more than 5% on fresh comments from Tesla CEO Elon Musk.
One catalyst could help lithium stocks recover, with one stock looking like a solid long-term buy now.
Weak guidance raised questions about the software company’s competitiveness in the current AI-centric environment.
SelectQuote reported earnings for its fourth fiscal quarter of 2024 earlier today.
Is it time to sell the the GPS technology specialist? One bank analyst thinks so.
Is it time to sell the the GPS technology specialist? One bank analyst thinks so.
RH stock spikes as it finally realizes the inflection point in demand it had been predicting.
SLQT earnings call for the period ending June 30, 2024.
Learn how to easily build a diversified portfolio from scratch. This one ticker represents more than 3,600 stocks, setting you up for ultimate stability.
NuScale stock might earn a profit in 2028. Can you wait that long?
S&P 500 inclusion is a big deal for Palantir but investors should expect short-term volatility in the stock.
Investors have two innovative stocks to choose from in this exciting comparison.
ChargePoint is adjusting to the reality of a smaller-than-forecasted EV market.
Better-than-expected trial data means Summit’s bispecific antibody could replace the blockbuster Keytruda as a standard of care for certain lung cancers.
Oracle delivered yet another quarter of solid order growth as demand for AI continues to soar.
Nvidia stock investors are curious about the price and the right time to sell the AI stock.
Investors perhaps expect Plug Power stock to explode if and when a green hydrogen boom arrives, but will it?